<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/jcm13237039</dc:identifier><dc:language>eng</dc:language><dc:creator>Sevil-Pérez, Anais</dc:creator><dc:creator>López-Antón, Raúl</dc:creator><dc:creator>Gracia-García, Patricia</dc:creator><dc:creator>de la Cámara, Concepción</dc:creator><dc:creator>Gascón-Catalán, Ana</dc:creator><dc:creator>Santabárbara, Javier</dc:creator><dc:title>The Association Between Major Depression and Alzheimer’s Disease Risk: Evidence from a 12-Year Longitudinal Study</dc:title><dc:identifier>ART-2024-141707</dc:identifier><dc:description>Background: The relationship between depression, particularly major depression (MD), as a risk factor for Alzheimer’s disease (AD) is well established; however, its precise role remains contested. Findings from the fourth wave of the ZARADEMP longitudinal study provide further insights into the association between MD and AD risk. Objectives: This study aimed to examine the association between MD and incident AD, controlling for established risk factors. Methods: The study analyzed 4803 participants, of whom 4057 were followed over a 12-year period as part of the ZARADEMP longitudinal study. Depression was assessed using the GMS-AGECAT, and dementia was diagnosed according to DSM-IV criteria. The association between MD and incident AD was evaluated using Cox proportional hazards regression models. Results: The incidence of AD was approximately twice as high in participants with MD compared to those without (relative risk = 2.07; 95% CI: 0.85–5.03; p = 0.123). This risk was nearly threefold higher in the fully adjusted model. Conclusions: These findings underscore a significant association between MD and an increased risk of AD, emphasizing the need for vigilant monitoring and potential early intervention among individuals diagnosed with MD.</dc:description><dc:date>2024</dc:date><dc:source>http://zaguan.unizar.es/record/148380</dc:source><dc:doi>10.3390/jcm13237039</dc:doi><dc:identifier>http://zaguan.unizar.es/record/148380</dc:identifier><dc:identifier>oai:zaguan.unizar.es:148380</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B15-17R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B15-23R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/G03-128</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/01-0255</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/03-0815</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/06-0617</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/12-02254</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/16-00896</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/19-01874</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/94-1562</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/97-1321E</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO-ISCIII/FIS/98-0103</dc:relation><dc:identifier.citation>Journal of Clinical Medicine 13, 23 (2024), 7039 [10 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>https://creativecommons.org/licenses/by/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>